Michael T. Rudd

Person

Collegeville, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Phosphinic amide prodrugs of tenofovir
- Patent number 11,826,375
- Issue date Nov 28, 2023
- Merck Sharp & Dohme LLC
- Manuel De Lera Ruiz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicycloheptane pyrrolidine orexin receptor agonists
- Patent number 11,680,060
- Issue date Jun 20, 2023
- Merck Sharp & Dohme LLC
- Stephane L. Bogen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl and heteroaryl ether derivatives as liver X receptor beta agon...
- Patent number 11,655,216
- Issue date May 23, 2023
- Merck Sharp & Dohme LLC
- Michael T. Rudd
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscari...
- Patent number 11,339,156
- Issue date May 24, 2022
- Merck Sharp & Dohme Corp.
- John J. Acton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscari...
- Patent number 11,149,036
- Issue date Oct 19, 2021
- MSD R&D (CHINA) CO., LTD
- John J. Acton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
5-alkyl pyrrolidine orexin receptor agonists
- Patent number 11,098,029
- Issue date Aug 24, 2021
- Merck Sharp & Dohme Corp.
- Stephane L. Bogen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
5-(pyridin-3-yl)oxazole allosteric modulators of the M4 muscarinic...
- Patent number 10,981,902
- Issue date Apr 20, 2021
- Merck Sharp & Dohme Corp.
- Jianming Bao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-aryl and N-heteroaryl piperidine derivatives as liver X receptor...
- Patent number 10,961,215
- Issue date Mar 30, 2021
- Merck Sharp & Dohme Corp.
- Michael T. Rudd
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscari...
- Patent number 10,933,056
- Issue date Mar 2, 2021
- Merck Sharp & Dohme Corp.
- John J. Acton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Piperidine derivatives as liver X receptor beta agonists, compositi...
- Patent number 10,894,775
- Issue date Jan 19, 2021
- Merck Sharp & Dohme Corp.
- Michael T. Rudd
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Homobispiperidinyl derivatives as liver X receptor beta agonists, c...
- Patent number 10,752,587
- Issue date Aug 25, 2020
- Merck Sharp & Dohme Corp.
- Michael T. Rudd
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscari...
- Patent number 10,512,638
- Issue date Dec 24, 2019
- Merck Sharp & Dohme Corp.
- Michael T. Rudd
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyanopyridine derivatives as liver X receptor beta agonists, compos...
- Patent number 10,239,849
- Issue date Mar 26, 2019
- Merck Sharp & Dohme Corp.
- Michael T. Rudd
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
HCV NS3 protease inhibitors
- Patent number 9,738,661
- Issue date Aug 22, 2017
- Merck Sharp & Dohme Corp.
- Nigel J. Liverton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Quinoline carboxamide and quinoline carbonitrile derivatives as mGl...
- Patent number 9,663,506
- Issue date May 30, 2017
- Merck Sharp & Dohme Corp.
- Christopher James Bungard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Quinoline carboxamide and quinoline carbonitrile derivatives as mGl...
- Patent number 9,636,337
- Issue date May 2, 2017
- Merck Sharp & Dohme Corp.
- Christopher James Bungard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HCV NS3 protease inhibitors
- Patent number 9,328,138
- Issue date May 3, 2016
- MSD Italia SRL
- Michael T. Rudd
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Quinoline carboxamide and quinoline carbonitrile derivatives as mGl...
- Patent number 9,278,960
- Issue date Mar 8, 2016
- Merck Sharp & Dohme Corp.
- Christopher James Bungard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrrolo[3,2-c]pyridines as TrkA kinase inhibitors
- Patent number 9,102,673
- Issue date Aug 11, 2015
- Merck Sharp & Dohme Corp.
- Barbara Hanney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Macrocyclic compounds as antiviral agents
- Patent number 8,927,569
- Issue date Jan 6, 2015
- Merck Sharp & Dohme Corp.
- Steven Harper
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hepatitis C virus NS3 protease inhibitors
- Patent number 8,828,930
- Issue date Sep 9, 2014
- Merck Sharp & Dohme Corp.
- Nigel J. Liverton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic compounds
- Patent number 8,591,878
- Issue date Nov 26, 2013
- Merck Sharp & Dohme Corp.
- John A. McCauley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HCV NS3 protease inhibitors
- Patent number 8,461,107
- Issue date Jun 11, 2013
- Merck Sharp & Dohme Corp.
- Nigel J. Liverton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HCV NS3 protease inhibitors
- Patent number 8,377,874
- Issue date Feb 19, 2013
- Merck Sharp & Dohme Corp.
- Nigel J. Liverton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HCV NS3 protease inhibitors
- Patent number 8,309,540
- Issue date Nov 13, 2012
- Merck Sharp & Dohme Corp.
- Nigel J. Liverton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
HCV NS3 protease inhibitors
- Patent number 8,278,322
- Issue date Oct 2, 2012
- Merck Sharp & Dohme Corp.
- M. Katharine Holloway
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HCV NS3 protease inhibitors
- Patent number 8,216,999
- Issue date Jul 10, 2012
- Merck Sharp & Dohme Corp.
- M. Katharine Holloway
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HCV NS3 protease inhibitors
- Patent number 7,879,797
- Issue date Feb 1, 2011
- Merck Sharp & Dohme Corp.
- M. Katharine Holloway
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
HCV NS3 protease inhibitors
- Patent number 7,470,664
- Issue date Dec 30, 2008
- Merck & Co., Inc.
- M. Katharine Holloway
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
3-HETEROARYL PYRROLIDINE AND PIPERIDINE OREXIN RECEPTOR AGONISTS
- Publication number 20240002359
- Publication date Jan 4, 2024
- Merck Sharp & Dohme LLC
- Stephane L. Bogen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-AMINO PYRROLIDINE AND PIPERIDINE MACROCYCLIC OREXIN RECEPTOR AGON...
- Publication number 20240002397
- Publication date Jan 4, 2024
- Merck Sharp & Dohme LLC
- Stephane L. Bogen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC UREA OREXIN RECEPTOR AGONISTS
- Publication number 20230391795
- Publication date Dec 7, 2023
- Merck Sharp & Dohme LLC
- Kira A. Armacost
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLOHEPTANE PYRROLIDINE OREXIN RECEPTOR AGONISTS
- Publication number 20230365533
- Publication date Nov 16, 2023
- Merck Sharp & Dohme LLC
- Stephane L. Bogen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYCLOPENTAPYRROLE OREXIN RECEPTOR AGONISTS
- Publication number 20230257348
- Publication date Aug 17, 2023
- Merck Sharp & Dohme LLC
- Stephane L. Bogen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL PYRROLIDINE AND PIPERIDINE OREXIN RECEPTOR AGONISTS
- Publication number 20230018413
- Publication date Jan 19, 2023
- MERCK SHARP & DOHME CORP.
- Stephane L. Bogen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRROLIDINE OREXIN RECEPTOR AGONISTS
- Publication number 20220144771
- Publication date May 12, 2022
- MERCK SHARP & DOHME CORP.
- Stephane L. Bogen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLOHEPTANE PYRROLIDINE OREXIN RECEPTOR AGONISTS
- Publication number 20220056017
- Publication date Feb 24, 2022
- MERCK SHARP & DOHME CORP.
- Stephane L. BOGEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARI...
- Publication number 20210380580
- Publication date Dec 9, 2021
- MERCK SHARP & DOHME CORP.
- John J. ACTON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHOSPHINIC AMIDE PRODRUGS OF TENOFOVIR
- Publication number 20210260082
- Publication date Aug 26, 2021
- MERCK SHARP & DOHME CORP.
- Manuel De Lera Ruiz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
5-ALKYL PYRROLIDINE OREXIN RECEPTOR AGONISTS
- Publication number 20200255403
- Publication date Aug 13, 2020
- MERCK SHARP & DOHME CORP.
- Stephane L. BOGEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ARYL AND HETEROARYL ETHER DERIVATIVES AS LIVER X RECEPTOR BETA AGON...
- Publication number 20200247754
- Publication date Aug 6, 2020
- MERCK SHARP & DOHME CORP.
- Michael T. Rudd
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARI...
- Publication number 20200207758
- Publication date Jul 2, 2020
- MERCK SHARP & DOHME CORP.
- John J. ACTON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
5-(PYRIDIN-3-YL)OXAZOLE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC...
- Publication number 20200109137
- Publication date Apr 9, 2020
- MERCK SHARP & DOHME CORP.
- Jianming BAO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARI...
- Publication number 20200069671
- Publication date Mar 5, 2020
- MERCK SHARP & DOHME CORP.
- John J. Acton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-ARYL AND N-HETEROARYL PIPERIDINE DERIVATIVES AS LIVER X RECEPTOR...
- Publication number 20200039951
- Publication date Feb 6, 2020
- MERCK SHARP & DOHME CORP.
- Michael T. Rudd
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PIPERIDINE DERIVATIVES AS LIVER X RECEPTOR BETA AGONISTS, COMPOSITI...
- Publication number 20190375716
- Publication date Dec 12, 2019
- MERCK SHARP & DOHME CORP.
- Michael T. Rudd
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARI...
- Publication number 20190000824
- Publication date Jan 3, 2019
- MERCK SHARP & DOHME CORP.
- John J. Acton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HOMOBISPIPERIDINYL DERIVATIVES AS LIVER X RECEPTOR BETA AGONISTS, C...
- Publication number 20180354901
- Publication date Dec 13, 2018
- MERCK SHARP & DOHME CORP.
- Michael T. Rudd
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyanopyridine Derivatives as Liver X Receptor Beta Agonists, Compos...
- Publication number 20180327374
- Publication date Nov 15, 2018
- MERCK SHARP & DOHME CORP.
- Michael T. Rudd
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bispiperidinyl Derivatives as Liver X Receptor Beta Agonists, Compo...
- Publication number 20180305332
- Publication date Oct 25, 2018
- MERCK SHARP & DOHME CORP.
- Shawn J. Stachel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quinoline Carboxamide and Quinoline Carbonitrile Derivatives as mGl...
- Publication number 20160158217
- Publication date Jun 9, 2016
- MERCK SHARP & DOHME CORP.
- Christopher James Bungard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Quinoline Carboxamide and Quinoline Carbonitrile Derivatives as mGl...
- Publication number 20160159744
- Publication date Jun 9, 2016
- MERCK SHARP & DOHME CORP.
- Christopher James Bungard
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HCV NS3 Protease Inhibitors
- Publication number 20150266897
- Publication date Sep 24, 2015
- MSD Italia S.R.L.
- Nigel J. Liverton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUINOLINE CARBOXAMIDE AND QUINOLINE CARBONITRILE DERIVATIVES AS mGl...
- Publication number 20140309227
- Publication date Oct 16, 2014
- Christopher James Bungard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HCV NS3 PROTEASE INHIBITORS
- Publication number 20140296136
- Publication date Oct 2, 2014
- Michael T. Rudd
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
- Publication number 20140155413
- Publication date Jun 5, 2014
- Barbara Hanney
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HCV NS3 PROTEASE INHIBITORS
- Publication number 20130178413
- Publication date Jul 11, 2013
- John A. McCauley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HEPATITIS C VIRUS NS3 PROTEASE INHIBITORS
- Publication number 20120121624
- Publication date May 17, 2012
- MERCK SHARP & DOHME CORP.
- Nigel J. Liverton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HCV NS3 PROTEASE INHIBITORS
- Publication number 20110046161
- Publication date Feb 24, 2011
- Nigel J. Liverton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Michael T. Rudd

Person

Patents Grantslast 30 patents

Phosphinic amide prodrugs of tenofovir

Bicycloheptane pyrrolidine orexin receptor agonists

Aryl and heteroaryl ether derivatives as liver X receptor beta agon...

3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscari...

3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscari...

5-alkyl pyrrolidine orexin receptor agonists

5-(pyridin-3-yl)oxazole allosteric modulators of the M4 muscarinic...

N-aryl and N-heteroaryl piperidine derivatives as liver X receptor...

3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscari...

Piperidine derivatives as liver X receptor beta agonists, compositi...

Homobispiperidinyl derivatives as liver X receptor beta agonists, c...

3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscari...

Cyanopyridine derivatives as liver X receptor beta agonists, compos...

HCV NS3 protease inhibitors

Quinoline carboxamide and quinoline carbonitrile derivatives as mGl...

Quinoline carboxamide and quinoline carbonitrile derivatives as mGl...

HCV NS3 protease inhibitors

Quinoline carboxamide and quinoline carbonitrile derivatives as mGl...

Substituted pyrrolo[3,2-c]pyridines as TrkA kinase inhibitors

Macrocyclic compounds as antiviral agents

Hepatitis C virus NS3 protease inhibitors

Therapeutic compounds

HCV NS3 protease inhibitors

HCV NS3 protease inhibitors

HCV NS3 protease inhibitors

HCV NS3 protease inhibitors

HCV NS3 protease inhibitors

HCV NS3 protease inhibitors

HCV NS3 protease inhibitors

Patents Applicationslast 30 patents

3-HETEROARYL PYRROLIDINE AND PIPERIDINE OREXIN RECEPTOR AGONISTS

3-AMINO PYRROLIDINE AND PIPERIDINE MACROCYCLIC OREXIN RECEPTOR AGON...

MACROCYCLIC UREA OREXIN RECEPTOR AGONISTS

BICYCLOHEPTANE PYRROLIDINE OREXIN RECEPTOR AGONISTS

CYCLOPENTAPYRROLE OREXIN RECEPTOR AGONISTS

HETEROARYL PYRROLIDINE AND PIPERIDINE OREXIN RECEPTOR AGONISTS

PYRROLIDINE OREXIN RECEPTOR AGONISTS

BICYCLOHEPTANE PYRROLIDINE OREXIN RECEPTOR AGONISTS

3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARI...

PHOSPHINIC AMIDE PRODRUGS OF TENOFOVIR

5-ALKYL PYRROLIDINE OREXIN RECEPTOR AGONISTS

ARYL AND HETEROARYL ETHER DERIVATIVES AS LIVER X RECEPTOR BETA AGON...

3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARI...

5-(PYRIDIN-3-YL)OXAZOLE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC...

3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARI...

N-ARYL AND N-HETEROARYL PIPERIDINE DERIVATIVES AS LIVER X RECEPTOR...

PIPERIDINE DERIVATIVES AS LIVER X RECEPTOR BETA AGONISTS, COMPOSITI...

3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARI...

HOMOBISPIPERIDINYL DERIVATIVES AS LIVER X RECEPTOR BETA AGONISTS, C...

Cyanopyridine Derivatives as Liver X Receptor Beta Agonists, Compos...

Bispiperidinyl Derivatives as Liver X Receptor Beta Agonists, Compo...

Quinoline Carboxamide and Quinoline Carbonitrile Derivatives as mGl...

Quinoline Carboxamide and Quinoline Carbonitrile Derivatives as mGl...

HCV NS3 Protease Inhibitors

QUINOLINE CARBOXAMIDE AND QUINOLINE CARBONITRILE DERIVATIVES AS mGl...

HCV NS3 PROTEASE INHIBITORS

TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF

HCV NS3 PROTEASE INHIBITORS

HEPATITIS C VIRUS NS3 PROTEASE INHIBITORS

HCV NS3 PROTEASE INHIBITORS